drugset / Trial / NCT00676806
A Phase II Study of Umbilical Cord Blood Transplantation
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to determine whether Umbilical Cord Transplantation (UCB) can be substituted for adult bone marrow cells in the standard stem cell transplant regimens used at this hospital for subjects who do not have stem cell donors.
Timeline
- Start
- 2005-07
- Primary completion
- 2013-07
- Completion
- 2014-07
Outcome
Outcome not reported
Stopped (Enrollment): “Slow accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 50 mg/kg | — |
| Subject | Cyclophosphamide | Other / unclassified | 60 mg/m2 | — |
| Subject | Fludarabine | Small molecule | 25 mg/m2 | — |
| Subject | Pentostatin | Small molecule | 4 mg/kg | — |
| Subject | Umbilical Cord Blood | Cell therapy | — | — |